title: Accelerated degradation of collagen membranes in diabetic rats is associated with increased infiltration of macrophages and blood vessels.
abstract: OBJECTIVE
  Increased collagenolytic activity in diabetes may compromise collagen membrane (CM) survival. Tetracycline (TTC) possesses anti-collagenolytic properties and delays CM degradation. This study evaluated macrophage and capillary infiltration within CMs in diabetic rats.
  
  
  METHODS
  Diabetes was induced in 20 Wistar rats by streptozotocin and 20 served as controls. Biotin-labeled CM discs were immersed in either TTC (50 mg/ml) or PBS. In each animal, 2 discs (TTC and control) were implanted under the parietal periosteum and rats were sacrificed at 2 or 4 weeks post-implantation. The area and thickness of the residual disc collagen were measured following staining with streptavidin, and the number of macrophages and blood vessels within the membranes was determined using specific antibodies (to CD68 and transglutaminase II, respectively).
  
  
  RESULTS
  Diabetes significantly reduced the area and thickness of the CMs, while TTC increased CM thickness significantly in both groups of rats at 2 and 4 weeks. Diabetes increased the number of macrophages (∼eightfold at 2 weeks and ∼fourfold at 4 weeks), but TTC had no significant effect. Finally, diabetes increased the number of blood vessels within the discs (∼threefold at 2 weeks and ∼twofold at 4 weeks), while TTC had no effect.
  
  
  CONCLUSIONS
  Diabetes increases degradation of native CMs and the number of blood vessels and macrophages within them. TTC immersion delays CM degradation without an apparent effect on macrophage and blood vessel penetration.
  
  
  CONCLUSIONS
  Enhanced CM degradation in diabetic conditions which impair guided regenerative procedure outcome is apparently related to increased blood vessel formation and macrophage infiltration.
authors.affiliation: Department of Periodontology and Implantology, Tel Aviv University Goldschleger School of Dental Medicine, POB 39040, 6997801, Tel Aviv, Israel. moseso@post.tau.ac.il.
authors.forename: Ofer
authors.initials: O
authors.lastname: Moses
authors.affiliation: Tel Aviv University Goldschleger School of Dental Medicine, POB 39040, 6997801, Tel Aviv, Israel.
authors.forename: Meizi
authors.initials: M
authors.lastname: Eliezer
authors.affiliation: Department of Periodontology and Implantology, Tel Aviv University Goldschleger School of Dental Medicine, POB 39040, 6997801, Tel Aviv, Israel.
authors.forename: Carlos
authors.initials: C
authors.lastname: Nemcovsky
authors.affiliation: Department of Periodontology and Implantology, Tel Aviv University Goldschleger School of Dental Medicine, POB 39040, 6997801, Tel Aviv, Israel.
authors.forename: Haim
authors.initials: H
authors.lastname: Tal
authors.affiliation: Department of Oral Biology, Tel Aviv University Goldschleger School of Dental Medicine, POB 39040, 6997801, Tel Aviv, Israel.
authors.forename: Miron
authors.initials: M
authors.lastname: Weinreb
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003094:Collagen / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D008567:Membranes, Artificial; D051381:Rats; D017208:Rats, Wistar; D012886:Skull / Q000601:surgery*; D013752:Tetracycline / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D008567:Membranes, Artificial; D003094:Collagen; D013752:Tetracycline
keywords: Blood vessels; Collagen; Diabetes; Macrophages; Rats; Tetracycline